Cargando…

Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009

BACKGROUND: Quantifying isoniazid resistant (INH-R) tuberculosis (TB) is important because isoniazid resistance reduces the probability of treatment success, may facilitate the spread of multidrug resistance, and may reduce the effectiveness of isoniazid preventive therapy (IPT). METHODOLOGY/PRINCIP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenkins, Helen E., Zignol, Matteo, Cohen, Ted
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146514/ https://www.ncbi.nlm.nih.gov/pubmed/21829557 http://dx.doi.org/10.1371/journal.pone.0022927

Ejemplares similares

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Are Survey-Based Estimates of the Burden of Drug Resistant TB Too Low? Insight from a Simulation Study
por: Cohen, Ted, et al.
Publicado: (2008)

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
por: Dean, Anna S., et al.
Publicado: (2020)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
por: Pienaar, Elsje, et al.
Publicado: (2018)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
por: Stagg, Helen R., et al.
Publicado: (2019)

Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya
por: Jezmir, Julia, et al.
Publicado: (2016)

Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting
por: Yuen, Courtney M, et al.
Publicado: (2020)

Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
por: Gagneux, Sebastien, et al.
Publicado: (2006)

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Global burden of childhood tuberculosis
por: Jenkins, Helen E.
Publicado: (2016)

The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey
por: Aia, Paul, et al.
Publicado: (2016)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
por: Shekar, Sandhya, et al.
Publicado: (2014)

In silico analyses of isoniazid and streptomycin resistance-associated mutations in Mycobacterium tuberculosis
por: Dasoondi, Rushikesh Singh, et al.
Publicado: (2023)

Trends in Azole Resistance in Aspergillus fumigatus, the Netherlands, 1994–2016
por: Buil, Jochem B., et al.
Publicado: (2019)

Trends of spinal tuberculosis research (1994–2015): A bibliometric study
por: Wang, Yiran, et al.
Publicado: (2016)

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
por: Seifert, Marva, et al.
Publicado: (2015)

Isoniazid-resistant tuberculosis: A problem we can no longer ignore
por: Sulis, Giorgia, et al.
Publicado: (2020)

Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis
por: Gerona, Roy, et al.
Publicado: (2016)

Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015–2017
por: Holland, David P., et al.
Publicado: (2019)

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance
por: Bergval, Indra L., et al.
Publicado: (2009)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
por: Denkinger, Claudia M., et al.
Publicado: (2014)

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study
por: Romanowski, Kamila, et al.
Publicado: (2019)

Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report
por: Li, Tsung-Lun, et al.
Publicado: (2021)

Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014
por: Smith, Catherine M, et al.
Publicado: (2017)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Isoniazid-induced liver disorder in the treatment of tuberculosis
por: Sivannan, Srinivasan, et al.
Publicado: (2018)

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis
por: Sarma, G. R. K.
Publicado: (2022)

Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis.
por: Shim, T. S., et al.
Publicado: (1997)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR
por: Sahebi, Leyla, et al.
Publicado: (2016)

Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
por: Thai, Phan Vuong Khac, et al.
Publicado: (2018)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2017)

Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium tuberculosis Isolates in Thailand
por: Charoenpak, Ratchanu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2qf1d9ckm1ttd9n6r7jgvelpjd